Centessa Pharmaceuticals PLC ADR (CNTA) — Strategic Asset Allocation Index
Centessa Pharmaceuticals PLC ADR (CNTA) has a Strategic Asset Allocation Index of 52.8% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $257.12 Million) total $257.12 Million, measured against net assets of $487.35 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Centessa Pharmaceuticals PLC ADR balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Centessa Pharmaceuticals PLC ADR Strategic Asset Allocation Index (2021–2025)
This chart shows how Centessa Pharmaceuticals PLC ADR's Strategic Asset Allocation Index has evolved across 4 annual periods from 2021 to 2025. As of March 2026, the index stands at 52.8%, representing strategic assets of $257.12 Million against net assets of $487.35 Million USD. For live market cap and overall valuation, see Centessa Pharmaceuticals PLC ADR market cap and net worth.
Annual Strategic Asset Allocation Index for Centessa Pharmaceuticals PLC ADR (2021–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Centessa Pharmaceuticals PLC ADR from 2021 to 2025, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CNTA book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 53.6% | $282.55 Million | $- | $282.55 Million | $526.86 Million | ▲ +53.6 pp |
| 2024 | 0.0% | $0.00 | $- | $0.00 | $401.55 Million | ▼ -0.3 pp |
| 2022 | 0.3% | $1.17 Million | $1.17 Million | $- | $336.17 Million | ▲ +0.3 pp |
| 2021 | 0.0% | $162.00K | $162.00K | $- | $491.55 Million | — |